H-D-Cys(Trt)-OH

H-D-Cys(Trt)-OH is a protected cysteine amino acid derivative in which the thiol side chain is protected as a trityl (Trt) thioether and the amino acid is presented as the free carboxylic acid with an N-terminal deuterium label (H-D at the amino nitrogen). The stereogenic center corresponds to the D-configuration of the cysteine backbone, enabling stereochemically defined incorporation into peptide and peptidomimetic sequences where cysteine geometry and side-chain chemistry are critical. The carboxylic acid and N-terminus participate in standard peptide coupling chemistry after appropriate activation, while the Trt group modulates thiol reactivity by suppressing disulfide formation and side reactions during synthesis. Deprotection strategies that remove Trt can regenerate the cysteine thiol for subsequent conjugation, native disulfide formation, or thioether/amide formation, making the compound a chiral, functionalized amino acid intermediate with deuterium as a tracking handle for analytical and mechanistic studies.

1. Protected Cysteine Peptide Synthesis

H-D-Cys(Trt)-OH is used in peptide building workflows where cysteine residues must remain stable under coupling and protecting-group conditions. The D-configured amino acid backbone provides defined stereochemistry at the alpha-carbon, while the Trt-protected thiol prevents premature oxidation, thiol alkylation, and undesired crosslinking during N- and C-terminal peptide bond formation. The free carboxylic acid supports activation-based peptide coupling to protected amino components, and the N-deuterium label can be retained through assembly for later mass spectrometric discrimination of cysteine-derived fragments. Peptide synthesis compatibility extends to producing cysteine-containing sequences and cysteine analogs that can be deprotected downstream to yield reactive thiols for controlled ligation and sequence-specific functionalization.

2. Bioconjugation Thiol Generation

H-D-Cys(Trt)-OH serves as a controlled precursor for thiol-based bioconjugation chemistries that require cysteine functional groups to be generated on demand. The Trt thio-protection strategy keeps the side-chain sulfur masked during handling and coupling, while the D-cysteine stereochemistry can be selected to probe stereochemical effects on conjugate stability and binding in chemical biology studies. Carboxylic acid functionality enables attachment to activated linkers or peptide carriers, and Trt removal can expose a thiol for conjugation to electrophiles such as maleimides, haloacetamides, or activated disulfide exchange partners. Deuterium at the amino nitrogen provides an additional isotopic tag useful for monitoring conjugation site incorporation and tracking thiol-derived species in downstream analytical workflows.

3. Mechanistic And Isotope Labeling

H-D-Cys(Trt)-OH is applied as an isotope-labeled amino acid intermediate for mechanistic and analytical research involving cysteine-containing pathways. The N-deuterium label enables discrimination of cysteine-derived fragments by mass spectrometry and can support studies of peptide fragmentation, thiol oxidation/reduction dynamics, and deprotection-dependent transformations. The Trt-protected thiol reduces background reactivity during sample preparation, allowing the compound to be incorporated into peptide substrates or model systems before thiol activation. The D-configuration further supports stereochemically defined comparisons in studies that distinguish epimeric or stereospecific behavior, aligning isotope labeling with amino acid chemistry and peptide science.

4. Peptidomimetic And Thiofunctional Scaffolds

H-D-Cys(Trt)-OH is suitable for synthetic organic chemistry routes that construct thiofunctional peptidomimetic scaffolds and cysteine-mimicking motifs. The protected amino acid framework provides a well-defined chiral handle for installing side-chain sulfur functionality while maintaining compatibility with amide bond formation and protecting-group management. Trt protection allows controlled late-stage thiol unveiling, enabling conversion into thioethers, disulfides, or sulfur-containing heterocycles depending on the chosen downstream transformation. The resulting sulfur-bearing intermediates can be used to generate structure-defined libraries for peptidomimetic design, including analogs where cysteine stereochemistry and sulfur oxidation state are tuned for chemical recognition studies.

5. Pharmaceutical Intermediate Preparation

H-D-Cys(Trt)-OH can be employed in pharmaceutical intermediate preparation where cysteine-containing fragments must be synthesized with controlled chemoselectivity. The combination of a protected thiol (Trt) and a free carboxylic acid supports manufacturing-style synthesis of peptide fragments, linker units, and protected cysteine building blocks that can later be assembled into larger molecules. The D-configuration and N-deuterium label can be leveraged for stereochemically defined intermediates and for isotopically traceable process or analytical steps when cysteine incorporation must be monitored. Downstream deprotection to regenerate thiol functionality enables formation of conjugation-ready intermediates used in fine chemical production and applied chemical manufacturing workflows that rely on cysteine sulfur reactivity at a specific stage.

1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

3. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

4. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet